- Home
- EXEL vs AUR Comparison
EXEL vs AUR Comparison
Compare EXEL & AUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EXEL | AUR |
|---|---|---|
| Founded | 1994 | 2017 |
| Country | United States | United States |
| Employees | N/A | 1900 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4B | 11.7B |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | EXEL | AUR |
|---|---|---|
| Price | $54.66 | $6.33 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 4 |
| Target Price | ★ $46.50 | $9.43 |
| AVG Volume (30 Days) | 2.5M | ★ 31.5M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 57.95 | N/A |
| EPS | ★ 0.79 | N/A |
| Revenue | ★ $452,477,000.00 | N/A |
| Revenue This Year | $13.61 | $407.30 |
| Revenue Next Year | $13.13 | $1,134.58 |
| P/E Ratio | $67.38 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $33.76 | $3.60 |
| 52 Week High | $53.93 | $8.57 |
Technical Indicators
Market Signals| Indicator | EXEL | AUR |
|---|---|---|
| Relative Strength Index (RSI) | 65.70 | 47.60 |
| Support Level | $40.17 | $3.84 |
| Resistance Level | N/A | $6.42 |
| Average True Range (ATR) | 1.52 | 0.33 |
| MACD | -0.04 | -0.03 |
| Stochastic Oscillator | 90.23 | 56.18 |
Price Performance
Historical ComparisonAbout EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About AUR Aurora Innovation Inc.
Aurora Innovation is a US autonomous driving provider for heavy trucks. The company produces and sells its Aurora Driver system, which includes hardware installed in a vehicle, software to autonomously drive it, and data management to maintain and improve the software. Aurora targets long-haul routes. The company currently offers its trucking-as-a-service model, where it owns and operates the trucks and makes deliveries for customers. The company plans to start selling its driver-as-a-service model next year, where fleet owners will own the trucks and Aurora's software will operate them.